| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |